Detalhe da pesquisa
1.
Rodent models of ketamine-induced cystitis.
Neurourol Urodyn
; 40(7): 1704-1719, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34350618
2.
Heteromer formation between cannabinoid type 1 and dopamine type 2 receptors is altered by combination cannabinoid and antipsychotic treatments.
J Neurosci Res
; 98(12): 2496-2509, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32881145
3.
Endothelin receptor heteromerization inhibits ß-arrestin function in HEK293 cells.
Can J Physiol Pharmacol
; 98(8): 531-540, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32744876
4.
Allosteric Cannabinoid Receptor 1 (CB1) Ligands Reduce Ocular Pain and Inflammation.
Molecules
; 25(2)2020 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-31968549
5.
Effects of intravitreal bevacizumab in Gram-positive and Gram-negative models of ocular inflammation.
Clin Exp Ophthalmol
; 47(5): 638-645, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30485637
6.
Modulation of the Endocannabinoid System Following Central Nervous System Injury.
Int J Mol Sci
; 20(2)2019 Jan 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-30658442
7.
Selective Cannabinoid 2 Receptor Agonists as Potential Therapeutic Drugs for the Treatment of Endotoxin-Induced Uveitis.
Molecules
; 24(18)2019 Sep 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-31540271
8.
Antagonism of Dopamine Receptor 2 Long Affects Cannabinoid Receptor 1 Signaling in a Cell Culture Model of Striatal Medium Spiny Projection Neurons.
Mol Pharmacol
; 89(6): 652-66, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27053685
9.
Biased Type 1 Cannabinoid Receptor Signaling Influences Neuronal Viability in a Cell Culture Model of Huntington Disease.
Mol Pharmacol
; 89(3): 364-75, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26700564
10.
The Endocannabinoid System as a Therapeutic Target in Glaucoma.
Neural Plast
; 2016: 9364091, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26881140
11.
Type 1 cannabinoid receptor ligands display functional selectivity in a cell culture model of striatal medium spiny projection neurons.
J Biol Chem
; 289(36): 24845-62, 2014 Sep 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-25037227
12.
Inhibition of endocannabinoid degradation in experimental endotoxemia reduces leukocyte adhesion and improves capillary perfusion in the gut.
J Basic Clin Physiol Pharmacol
; 24(1): 27-33, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23382309
13.
Topical analgesics for acute corneal pain: current options and emerging therapeutics.
J Cataract Refract Surg
; 49(11): 1160-1167, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37232414
14.
Why support a separate medical access framework for cannabis?
CMAJ
; 189(28): E927-E928, 2017 07 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-28716846
15.
Indirect sympatholytic actions at ß-adrenoceptors account for the ocular hypotensive actions of cannabinoid receptor agonists.
J Pharmacol Exp Ther
; 339(3): 757-67, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21885619
16.
Endothelin B receptor dysfunction mediates elevated myogenic tone in cerebral arteries from aged male Fischer 344 rats.
Geroscience
; 43(3): 1447-1463, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33403617
17.
Discovery of a Biased Allosteric Modulator for Cannabinoid 1 Receptor: Preclinical Anti-Glaucoma Efficacy.
J Med Chem
; 64(12): 8104-8126, 2021 06 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-33826336
18.
Ligand- and heterodimer-directed signaling of the CB(1) cannabinoid receptor.
Mol Pharmacol
; 77(1): 1-9, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19837905
19.
Combining SRET2 and BiFC to Study GPCR Heteromerization and Protein-Protein Interactions.
Methods Mol Biol
; 1947: 199-215, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30969418
20.
Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol-dimethylheptyl at the type 1 and type 2 cannabinoid receptors.
Br J Pharmacol
; 176(10): 1455-1469, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29981240